Skip to main content
Contact Us
Subscribe
E-Edition
66°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Cybin Inc
(NY:
CYBN
)
0.3500
+0.0040 (+1.16%)
Official Closing Price
Updated: 8:00 PM EDT, Apr 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Cybin Inc
< Previous
1
2
...
10
11
12
13
14
15
16
17
Next >
PsychedelicNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Announces FDA IND Authorization of Potentially Pivotal Study
October 26, 2021
Via
Investor Brand Network
Exposures
Product Safety
North America Continues Leading The Way In Psychedelic Wellness
October 26, 2021
Palm Beach, FL –October 26, 2021 – FinancialNewsMedia.com News Commentary – The global psychedelic drugs market remains at an early stage in its life cycle, with most companies currently developing...
Via
FinancialNewsMedia
Cybin Announces FDA Investigational New Drug Authorization of Cybin’s Sponsored Feasibility Study Using Kernel Flow Technology
October 26, 2021
From
Cybin Inc.
Via
Business Wire
Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Files Patent Application Amid ‘New Era’ of Psychedelic Medicine
October 20, 2021
Via
Investor Brand Network
Topics
Intellectual Property
Exposures
Intellectual Property
PsychedelicNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Announces Completion of 74 In-Vitro and In-Vivo Evaluations of Expanding Portfolio
October 19, 2021
Via
Investor Brand Network
Cybin Announces Completion of 74 Pre-Clinical Psychedelic Molecule Studies
October 19, 2021
From
Cybin Inc.
Via
Business Wire
PsychedelicNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Files International Patent Application in Continued Expansion of IP Portfolio
October 12, 2021
Via
Investor Brand Network
Topics
Intellectual Property
Exposures
Intellectual Property
Cybin Files an International Patent Application Covering Psychedelic Delivery Methods
October 12, 2021
From
Cybin Inc.
Via
Business Wire
U.S. Is Dominating Psychedelic Drugs Market Due To Growing Acceptance For Treating Depression & Rise In Product Approvals
October 12, 2021
Palm Beach, FL –October 12, 2021 – FinancialNewsMedia.com News Commentary – After being relegated to the margins of sincere scientific examination for about the last several decades, growing...
Via
FinancialNewsMedia
PsychedelicNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Poised Amid New Research Surrounding Psilocybin
October 11, 2021
Via
Investor Brand Network
Strong Pipeline of Drugs for Treatment Of Psychotic Disorders Anticipated To Drive The Market Through 2028
October 11, 2021
Palm Beach, FL –October 11, 2021 – FinancialNewsMedia.com News Commentary – There is a high demand for more advanced products for the treatment and maintenance of severe mental disorders. Thus,...
Via
FinancialNewsMedia
Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Announces New Executives, Internal Promotions
October 08, 2021
Via
Investor Brand Network
InvestorNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Announces Achievement of Adelia Milestones
October 07, 2021
Via
Investor Brand Network
Cybin Announces Additional Adelia Milestone Achievements
October 07, 2021
From
Cybin Inc.
Via
Business Wire
PsychedelicNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Appoints New Executives, Promotes Team Members
October 01, 2021
Via
Investor Brand Network
InvestorNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Appoints New Executives, Promotes Team Members
October 01, 2021
Via
Investor Brand Network
Cybin Announces Appointment of Dr. Amir Inamdar as Chief Medical Officer for European Operations and Dr. Geoff Varty as the Head of Research and Development
October 01, 2021
From
Cybin Inc.
Via
Business Wire
NetworkNewsAudio – Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Bringing Therapeutic Options to Diseases with Unmet Needs
September 30, 2021
Via
Investor Brand Network
Topics
Cannabis
Exposures
Cannabis
Psychedelics Renaissance Underway as Paradigm Shifting Cure for Depression Potentially Discovered
September 28, 2021
Via
FinancialNewsMedia
Topics
Law Enforcement
Exposures
Legal
Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Leading Out in Mental Health Treatment Innovation
September 27, 2021
Via
Investor Brand Network
Exposures
COVID-19
InvestorNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) CEO to Present in Two Upcoming Investor Conferences
September 27, 2021
Via
Investor Brand Network
Investors Turning to Psychedelic Market as Renaissance Continues into New Wave of Diseases
September 27, 2021
Via
Investor Brand Network
Topics
Cannabis
Exposures
Cannabis
Cybin to Present at Upcoming Cantor and Benzinga Investor Conferences
September 27, 2021
From
Cybin Inc.
Via
Business Wire
PsychedelicNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Garners Attention as ‘Emerging Leader in the Psychedelic Therapeutics Space’
September 24, 2021
Via
Investor Brand Network
$10 Billion Sackler Opioid Settlement Closes Chapter, Psychedelic Chapter Begins
September 15, 2021
Via
FinancialNewsMedia
Cybin to Present at the H.C. Wainwright 23rd Annual Global Investment Conference on September 13th
September 09, 2021
From
Cybin Inc.
Via
Business Wire
Cybin Announces Additional Adelia Milestone Achievements
August 31, 2021
From
Cybin Inc.
Via
Business Wire
Cybin Files Two Additional International Patent Applications in Support of the Company’s Research Phase Programs
August 19, 2021
From
Cybin Inc.
Via
Business Wire
Cybin Files 14th Patent Application Further Strengthening its IP Portfolio and Receives a Favorable Patent Claim Opinion
August 17, 2021
From
Cybin Inc.
Via
Business Wire
Cybin Announces Election of Theresa Firestone as Director, Results of Shareholders’ Meeting and Adoption of Shareholder Rights Plan
August 16, 2021
From
Cybin Inc.
Via
Business Wire
< Previous
1
2
...
10
11
12
13
14
15
16
17
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.